Žarko Kulić

647 total citations · 1 hit paper
20 papers, 434 citations indexed

About

Žarko Kulić is a scholar working on Complementary and alternative medicine, Molecular Biology and Neurology. According to data from OpenAlex, Žarko Kulić has authored 20 papers receiving a total of 434 indexed citations (citations by other indexed papers that have themselves been cited), including 8 papers in Complementary and alternative medicine, 7 papers in Molecular Biology and 7 papers in Neurology. Recurrent topics in Žarko Kulić's work include Ginkgo biloba and Cashew Applications (7 papers), Neurological Disease Mechanisms and Treatments (6 papers) and Respiratory and Cough-Related Research (5 papers). Žarko Kulić is often cited by papers focused on Ginkgo biloba and Cashew Applications (7 papers), Neurological Disease Mechanisms and Treatments (6 papers) and Respiratory and Cough-Related Research (5 papers). Žarko Kulić collaborates with scholars based in Germany, Switzerland and United Kingdom. Žarko Kulić's co-authors include Michael Heinrich, Banaz Jalil, Heiko M. Möller, Olivier Potterat, Javier Echeverría, Mona Abdel‐Tawab, Lyndy J. McGaw, John M. Pezzuto, Martin D. Lehner and Lixiang Zhai and has published in prestigious journals such as SHILAP Revista de lepidopterología, Journal of Bacteriology and International Journal of Molecular Sciences.

In The Last Decade

Žarko Kulić

18 papers receiving 427 citations

Hit Papers

Best Practice in the chemical characterisation of extract... 2022 2026 2023 2024 2022 40 80 120
What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

  1. Best Practice in the chemical characterisation of extracts used in pharmacological and toxicological research—The ConPhyMP—Guidelines12
    2022 142 citations Michael Heinrich, Banaz Jalil et al. Frontiers in Pharmacology profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Žarko Kulić Germany 9 215 118 107 67 48 20 434
Pin‐Ho Pan Taiwan 12 171 0.8× 116 1.0× 57 0.5× 69 1.0× 38 0.8× 15 480
Dongling Liu China 11 163 0.8× 58 0.5× 104 1.0× 81 1.2× 35 0.7× 15 494
Zibo Dong China 12 247 1.1× 80 0.7× 88 0.8× 54 0.8× 25 0.5× 37 477
Qingjun Cao China 9 156 0.7× 100 0.8× 73 0.7× 62 0.9× 64 1.3× 14 430
Neşe Başak Türkiye 12 145 0.7× 60 0.5× 56 0.5× 56 0.8× 24 0.5× 20 498
Hsin-Yi Lo Taiwan 11 199 0.9× 113 1.0× 65 0.6× 38 0.6× 106 2.2× 13 534
Qiongtao Song China 12 167 0.8× 85 0.7× 68 0.6× 22 0.3× 43 0.9× 18 383
Guang Hai Yan China 14 184 0.9× 82 0.7× 76 0.7× 71 1.1× 44 0.9× 19 519
Kyung Hwan Jegal South Korea 13 348 1.6× 74 0.6× 74 0.7× 66 1.0× 29 0.6× 30 601
Xiaoyan Dang China 11 268 1.2× 72 0.6× 35 0.3× 36 0.5× 40 0.8× 18 582

Countries citing papers authored by Žarko Kulić

Since Specialization
Citations

This map shows the geographic impact of Žarko Kulić's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Žarko Kulić with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Žarko Kulić more than expected).

Fields of papers citing papers by Žarko Kulić

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Žarko Kulić. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Žarko Kulić. The network helps show where Žarko Kulić may publish in the future.

Co-authorship network of co-authors of Žarko Kulić

This figure shows the co-authorship network connecting the top 25 collaborators of Žarko Kulić. A scholar is included among the top collaborators of Žarko Kulić based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Žarko Kulić. Žarko Kulić is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Kulić, Žarko, et al.. (2025). NMR Chemical Shifts of Common Flavonoids. Planta Medica. 92(1). 58–80.
2.
Emanuel, Jackson, Jan Papies, Julia M. Adler, et al.. (2023). In vitro and in vivo effects of Pelargonium sidoides DC. root extract EPs® 7630 and selected constituents against SARS-CoV-2 B.1, Delta AY.4/AY.117 and Omicron BA.2. Frontiers in Pharmacology. 14. 1214351–1214351. 6 indexed citations
3.
Fang, Lei, Liang Zhou, Žarko Kulić, et al.. (2023). EPs® 7630 Stimulates Tissue Repair Mechanisms and Modifies Tight Junction Protein Expression in Human Airway Epithelial Cells. International Journal of Molecular Sciences. 24(13). 11230–11230. 4 indexed citations
4.
5.
Kulić, Žarko, et al.. (2023). Sourcing Shikimic Acid from Waste Streams of Ginkgo biloba Leaf Extract Production. ACS Sustainable Chemistry & Engineering. 11(13). 4943–4947. 3 indexed citations
6.
Kulić, Žarko, et al.. (2022). Short Lecture “Flavonoid sulfates in Pelargonium sidoides root extract EPs® 7630”. Planta Medica. 88(15). 1428–1429. 1 indexed citations
7.
Kulić, Žarko, Martin D. Lehner, & Gunnar P.H. Dietz. (2022). Ginkgo biloba leaf extract EGb 761® as a paragon of the product by process concept. Frontiers in Pharmacology. 13. 1007746–1007746. 23 indexed citations
8.
Heinrich, Michael, Banaz Jalil, Mona Abdel‐Tawab, et al.. (2022). Best Practice in the chemical characterisation of extracts used in pharmacological and toxicological research—The ConPhyMP—Guidelines12. Frontiers in Pharmacology. 13. 953205–953205. 142 indexed citations breakdown →
9.
Heinrich, Michael, Banaz Jalil, Mona Abdel‐Tawab, et al.. (2022). Reporting guidelines for medicinal plant extracts used in pharmacological and toxicological research: ConPhyMP. SHILAP Revista de lepidopterología. 7(2). 1 indexed citations
10.
11.
Kulić, Žarko, et al.. (2021). A Detailed View on the Proanthocyanidins in Ginkgo Extract EGb 761. Planta Medica. 88(5). 398–404. 14 indexed citations
12.
Papies, Jan, Jackson Emanuel, Nicolas Heinemann, et al.. (2021). Antiviral and Immunomodulatory Effects of Pelargonium sidoides DC. Root Extract EPs® 7630 in SARS-CoV-2-Infected Human Lung Cells. Frontiers in Pharmacology. 12. 757666–757666. 27 indexed citations
13.
Bauer, Rudolf, et al.. (2021). HPLC-UV/HRMS methods for the unambiguous detection of adulterations of Ginkgo biloba leaves with Sophora japonica fruits on an extract level. Pharmaceutical Biology. 59(1). 436–441. 11 indexed citations
14.
15.
Luderer, Gunnar, et al.. (2021). Proanthocyanidines from EGb 761® improve impaired short term memory. Planta Medica. 2 indexed citations
16.
17.
Booker, Anthony, Banaz Jalil, Eike Reich, et al.. (2015). The authenticity and quality of Rhodiola rosea products. Phytomedicine. 23(7). 754–762. 71 indexed citations
18.
19.
Holert, Johannes, Žarko Kulić, Osman Yücel, et al.. (2012). Degradation of the Acyl Side Chain of the Steroid Compound Cholate in Pseudomonas sp. Strain Chol1 Proceeds via an Aldehyde Intermediate. Journal of Bacteriology. 195(3). 585–595. 35 indexed citations
20.
Orbán, Erika, Gábor Mező, Gabriella Csı́k, et al.. (2010). In vitro degradation and antitumor activity of oxime bond-linked daunorubicin–GnRH-III bioconjugates and DNA-binding properties of daunorubicin–amino acid metabolites. Amino Acids. 41(2). 469–483. 63 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Pin‐Ho Pan Breakdown of academic impact, for papers by Dongling Liu Breakdown of academic impact, for papers by Zibo Dong Breakdown of academic impact, for papers by Qingjun Cao Breakdown of academic impact, for papers by Neşe Başak Breakdown of academic impact, for papers by Hsin-Yi Lo Breakdown of academic impact, for papers by Qiongtao Song Breakdown of academic impact, for papers by Guang Hai Yan Breakdown of academic impact, for papers by Kyung Hwan Jegal Breakdown of academic impact, for papers by Xiaoyan Dang
Rankless by CCL
2026